Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Thyroid mimetic as an option for lowering low-density lipoprotein.

Literature DB >> 18187579

Thyroid mimetic as an option for lowering low-density lipoprotein.

Scott M Grundy¹.

Abstract

Mesh：

Substances：

Year: 2008 PMID： 18187579 PMCID： PMC2206548 DOI： 10.1073/pnas.0705959104

Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN： 0027-8424 Impact factor: 11.205

× No keyword cloud information.

20 in total

1. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors:
Journal: Circulation Date: 2002-12-17 Impact factor: 29.690

2. ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins.

Authors: Richard C Pasternak; Sidney C Smith; C Noel Bairey-Merz; Scott M Grundy; James I Cleeman; Claude Lenfant
Journal: Circulation Date: 2002-08-20 Impact factor: 29.690

3. Effects of the thyroid hormone receptor agonist GC-1 on metabolic rate and cholesterol in rats and primates: selective actions relative to 3,5,3'-triiodo-L-thyronine.

Authors: Gary J Grover; Donald M Egan; Paul G Sleph; Blake C Beehler; Grazia Chiellini; Ngoc-Ha Nguyen; John D Baxter; Thomas S Scanlan
Journal: Endocrinology Date: 2003-12-30 Impact factor: 4.736

Review 4. Coronary heart disease in high-risk populations: lessons from Finland.

Authors: S M Grundy; L Wilhelmsen; G Rose; R W Campbell; G Assman
Journal: Eur Heart J Date: 1990-05 Impact factor: 29.983

5. The coronary drug project--findings with regard to estrogen, dextrothyroxine, clofibrate and niacin.

Authors: J Stamler
Journal: Adv Exp Med Biol Date: 1977 Impact factor: 2.622

Review 6. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Authors: Scott M Grundy; James I Cleeman; C Noel Bairey Merz; H Bryan Brewer; Luther T Clark; Donald B Hunninghake; Richard C Pasternak; Sidney C Smith; Neil J Stone
Journal: Circulation Date: 2004-07-13 Impact factor: 29.690

7. The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans.

Authors: Anders Berkenstam; Jens Kristensen; Karin Mellström; Bo Carlsson; Johan Malm; Stefan Rehnmark; Neeraj Garg; Carl Magnus Andersson; Mats Rudling; Folke Sjöberg; Bo Angelin; John D Baxter
Journal: Proc Natl Acad Sci U S A Date: 2007-12-26 Impact factor: 11.205

8. Selective thyroid hormone receptor-beta activation: a strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability.

Authors: Gary J Grover; Karin Mellström; Liu Ye; Johan Malm; Yi-Lin Li; Lars-Göran Bladh; Paul G Sleph; Mark A Smith; Rocco George; Björn Vennström; Kasim Mookhtiar; Ryan Horvath; Jessica Speelman; Donald Egan; John D Baxter
Journal: Proc Natl Acad Sci U S A Date: 2003-07-29 Impact factor: 11.205

9. Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits.

Authors: P T Ma; G Gil; T C Südhof; D W Bilheimer; J L Goldstein; M S Brown
Journal: Proc Natl Acad Sci U S A Date: 1986-11 Impact factor: 11.205